Clinical meaning of serum trimethylamine oxide, N-terminal-pro-brain natriuretic peptide, hypoxia-inducible factor-1α and left ventricular function and pregnancy outcome in patients with pregnancy-induced hypertension

  • YunTai Liang Shijiazhuang Fourth Hospital
  • YunTai Liang Shijiazhuang Fourth Hospital
  • Yue Wu Shijiazhuang Fourth Hospital
  • LiHong Duan Chinese People's Liberation Army 66172 Army Hospital
  • ChunHui Xiao Shijiazhuang Fourth Hospital
  • ZeYa Ren Shijiazhuang Fourth Hospital
Keywords: Gestational hypertension, Trimethylamine oxide, N-terminal-pro-brain natriuretic peptide, Hypoxia-inducible factor-1α, Left ventricular function, Pregnancy outcome

Abstract


Purpose: To figure out the clinical meaning of serum trimethylamine oxide (TMAO), N-terminal-pro-brain natriuretic peptide (NT-proBNP) and hypoxia-inducible factor-1α (HIF-1α) with left ventricular function and pregnancy outcome in patients with pregnancy-induced hypertension.

Methods: From January 2018 to October 2020, taking 117 patients with gestational hypertension was as the research objects, assignation of them was into the gestational hypertension (pregnancy-induced hypertension group, 55 cases), mild preeclampsia (the mild PE, 43 cases) and severe preeclampsia (the severe PE, 19 cases) in the light of the severity of the disease. Analysis of the link of serum TMAO, NT-proBNP and HIF-1α with severity of disease and cardiac function indexes in patients with gestational hypertension was conducted; All patients were followed up to the end of pregnancy, and analysis of the predictive value of serum TMAO, NT-proBNP and HIF-1α on pregnancy outcome in patients was conducted.

Results:  The serum TMAO and NT-proBNP of patients were elevated, while HIF-1α was reduced with the severity of the disease (P < 0.05). The serum TMAO, NT-proBNP in patients with gestational hypertension were positively linked, but HIF-1α was negatively correlated with the severity of the disease (P < 0.05).  Left ventricular end-diastolic volume (LVEDV) and left ventricular end-systolic volume (LVESV) were elevated in gestational hypertension patients, while ejection fraction (LVEF) was reduced with the severity of disease (P < 0.05). The serum TMAO, NT-probNP and HIF-1α were implicated in LVEDV, LVESV and LVEF values in patients with gestational hypertension (P < 0.05). The serum TMAO and NT-probNP in the poor pregnancy outcome were elevated vs. the good pregnancy outcome, but HIF-1α was reduced (P < 0.05). The AUC of the prediction of combined detection of serum TMAO, NT-probNP and HIF-1α on pregnancy outcome was greater vs. alone detection of each index (P < 0.05).

Conclusion: Serum TMAO, NT-proBNP and HIF-1α in patients with gestational hypertension are linked with disease severity and cardiac function, and have predictive and evaluative values for disease severity and pregnancy outcome.

References

[1]Shen M, Smith GN, Rodger M, et al. Comparison of risk factors and outcomes of gestational hypertension and pre-eclampsia[J]. Plos One, 2017, 12(4):e0175914.
[2]Yu L, Zhou Q, Peng Q, et al. Velocity vector imaging echocardiography and NT‐proBNP study of fetal cardiac function in pregnancy‐induced maternal hypertension[J]. J Clin Ultrasound, 2019, 47(5):285-291.
[3]Yu H, He Y, Mao Z, et al. Hypertensive disorders during pregnancy and elevated blood pressure in the offspring: A systematical review and meta-analysis protocol[J]. Medicine, 2019, 98(20):e15677.
[4]Borghese MM, Walker M, Helewa ME, et al. Association of perfluoroalkyl substances with gestational hypertension and preeclampsia in the MIREC study[J]. Environ Int, 2020, 141(8):105789.
[5]Wang J, Wu X. The effects of mitochondrial dysfunction on energy metabolism switch by HIF-1α signalling in granulosa cells of polycystic ovary syndrome[J]. Endokrynol Pol, 2020, 71(2):134-145.
[6]Jie Le. Obstetrics and Gynecology. Fourth Edition [M]. Beijing: People's Health Publishing House, 1996: 113-113.
[7]Chinese Medical Association Obstetrics and Gynecology Branch Gestational Hypertension Disorders Group. Guidelines for the diagnosis and treatment of pregnancy-induced hypertension (2015) [J]. Chinese Journal of Obstetrics and Gynecology, 2015, 50(10):721-728.
[8]Hussain A, Sun W, Deswal A, et al. Association of NT-ProBNP, Blood Pressure, and Cardiovascular Events[J]. J Am Coll Cardiol, 2021, 77(5):559-571.
[9]Pan ML, Chen LR, Tsao HM, et al. Risk of gestational hypertension-preeclampsia in women with preceding endometriosis: A nationwide population-based study[J]. Plos One, 2017, 12(7):e0181261.
[10]Qiu D, Wu J, Li M, et al. Impaction of factors associated with oxidative stress on the pathogenesis of gestational hypertension and preeclampsia: A Chinese patients based study[J]. Medicine, 2021, 100(11):e23666.
[11]Kaestner F, Rapp D, Trudzinski FC, et al. High Serum Bilirubin Levels, NT-pro-BNP, and Lactate Predict Mortality in Long-Term, Severely Ill Respiratory ECMO Patients[J]. ASAIO J, 2018, 64(2):232-237.
[12]Wanli Wang, Yinhuan Li, Yingchun Guo, et al. Correlation between cardiac function impairment and plasma NT-proBNP levels in patients with pregnancy-induced hypertension [J]. Genomics and Applied Biology, 2018, 37(3): 956-962.
[13]Sadlecki P, Grabiec M, Walentowicz-Sadlecka M. Prenatal Clinical Assessment of NT-proBNP as a Diagnostic Tool for Preeclampsia, Gestational Hypertension and Gestational Diabetes Mellitus[J]. Plos One, 2016, 11(9):e0162957.
[14]Xiaoning Wang, Li Geng, Kun Cui, et al. Changes of left ventricular structure and function in patients with gestational hypertension and their relationship with neonatal growth and development [J]. Shandong Medicine, 2020, 60(18):5- 8.
[15]Kumari M, Kovach T, Sheehy B, et al. Circulating NT-proBNP but not soluble corin levels were associated with preeclampsia in pregnancy-associated hypertension[J]. Clin Biochem, 2019, 67(5):12-15.
[16]Naeem B, Ayub A, Aly AM, et al. Urinary NT-proBNP as a potential non-invasive biomarker for screening of pulmonary hypertension in preterm infants: a pilot study[J]. J Perinatol, 2020, 40(4):628-632.
[17]Dongxue Yang, Qiuju Wei, Zhenmin Hao. Clinical application of tissue Doppler ultrasonography in monitoring left ventricular function in patients with gestational hypertension [J]. Chinese Journal of Prevention and Treatment of Endemic Diseases, 2017, 32(1):84-84.
[18]Haixia Wang, Kele Li, Baohong Zhang. The relationship between plasma N-terminal brain natriuretic peptide precursor level and left ventricular diastolic function and blood pressure in patients with pregnancy-induced hypertension [J]. Shandong Medicine, 2017, 57(1):59-60, 63.
[19]Li G, Lu WH, Wu XW, et al. Admission hypoxia-inducible factor 1α levels and in-hospital mortality in patients with acute decompensated heart failure[J]. BMC Cardiovasc Disord, 2015, 15(6):79-85.
[20]Xi Tan, Fan Yu, Yiduo Zhang. Clinical application value of NT-proBNP in common complications of pregnancy [J]. Chongqing Medical Journal, 2020, 49(12):1946-1950.
[21]Liu Y, Luo Q, Su Z, et al. Suppression of Myocardial HIF-1α Compromises Metabolic Adaptation and Impairs Cardiac Function in Patients with Cyanotic Congenital Heart Disease During Puberty[J]. Circulation, 2021, 143(23):2254-2272.
[22]Roberts LM, Davis GK, Homer CS. Pregnancy with gestational hypertension or preeclampsia: A qualitative exploration of women's experiences[J]. Midwifery, 2017, 46(3):17-23.
[23]Dai C, Zhao C, Xu M, et al. Serum lncRNAs in early pregnancy as potential biomarkers for the prediction of pregnancy-induced hypertension, including preeclampsia[J]. Mol Ther Nucleic Acids, 2021, 24(3):416-425.
Published
2022/11/09
Section
Original paper